Recalls / Active ingredient / Vilanterol Trifenatate
Vilanterol Trifenatate
3 FDA drug recalls involving the active ingredient “Vilanterol Trifenatate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2023-12-12 | Class III | ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 | GlaxoSmithKline LLC |
| 2021-03-15 | Class II | Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) 100 mcg/62.5 mcg/25 mcg; | Cardinal Health Inc. |
| 2021-03-15 | Class II | TRELEGY ELLIPTA (FLUTICASONE FUROATE, UMEDIDINIUM AND VILANTEROL INHALATION POWDER) 100-62.5-25MCG 60; NDC/UPC | Cardinal Health Inc. |